Follow the Avacta Group Plc stock price and the full insider trade history of the company, a listed issuer based in United Kingdom. Shares are quoted on UK GB, under the supervision of RNS (LSE). The latest transaction was disclosed on 2 September 2024 (Grant). Among the most active insiders: Tony Gardiner. All data is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
5 of 5 declarations
Avacta Group Plc is a UK-based company focused on developing diagnostic and therapeutic technologies based on proteins. It emphasizes innovation in the healthcare and biotechnology sectors.